First Pass Due Diligence

Primary consideration of Asset/Candidate/Partner

  • Technology analysis & First-in class or Best-in class analysis
  • Fit with Major therapeutic focus of BusStim
  • BusStim Management/Network capabilities to take on and work with Asset
  • Management capability and strengths of Biotech Partner
  • Competitive Landscape: Clinical and Pre-Clinical
  • Market and Licensing attractiveness of technology
  • Risk analysis on partnership and technology
  • IP viability

Secondary consideration of Asset/Candidate/Partner

  • Financial Strengths of Partner
  • Viability of Grants

Where to Find Us:


Business Stimulant Consultants, LLC

3240 Henry Hudson Parkway

Suite 7E

Riverdale, NY 10463

Phone: 917-482-5642

What's New

Print Print | Sitemap
© Business Stimulant Consultants